News & Events

Amyloid protein in patients with frontotemporal dementia

The diagnosis of Alzheimer’s disease and frontotemporal dementia or FTD can be hard. The use of biomarkers such as the levels of different proteins in the cerebrospinal fluid allows to improve the accuracy of the diagnosis. Specifically, protein levels related...

Laura Cervera defends her doctoral thesis

Laura Cervera has defended her doctoral thesis today The thesis, entitled “Assessing the role of copy number variations, mitochondrial DNA and microRNAs in neurodegenerative disorders” has been directed by Dr. Jordi Clarimón and tutored by Dr. Alberto...

How do Alzheimer’s biomarkers change over time?

Biomarkers for the diagnosis of Alzheimer’s disease The characteristic symptoms of Alzheimer’s disease, such as progressive memory loss or other cognitive deficits and behavioral disorders, can make us suspect the diagnosis of this disease. This suspicion...

Super-resolution is here for amyloid plaques

Non-fibrillar amyloid-β (Aβ) plaques are considered to be a critical component of Alzheimer’s disease. Characterization of these species comes mainly from studies in cellular or animal models, but there is little data in intact human samples due to the lack of...

III Symposium of the DEGESCO Consortium

On May 16th, the III Symposium of the DEGESCO Consortium on Dementia Genetics will be held in Málaga, in the context of the VI Málaga Alzheimer Conference, sponsored by CIBERNED and the Andalusian Institute of Neuroscience. During the DEGESCO symposium, the ongoing...